Description

1,2,3,4-Tetrahydroisoquinolin-7-ol (CAS No. 30798-64-2) is a high-purity organic compound with the molecular formula C₉H₁₁NO. This heterocyclic amine derivative is widely utilized in pharmaceutical research, medicinal chemistry, and neurochemical studies due to its structural similarity to biologically active isoquinoline alkaloids. The compound features a tetrahydroisoquinoline core with a hydroxyl group at the 7-position, making it a valuable intermediate for the synthesis of more complex molecules. Our product is rigorously tested for purity and consistency, ensuring reliable performance in your laboratory applications. Available in various quantities to suit research-scale and process development needs.

Properties

• CAS Number: 30798-64-2
• Complexity: 138
• IUPAC Name: 1,2,3,4-tetrahydroisoquinolin-7-ol
• InChI: InChI=1S/C9H11NO/c11-9-2-1-7-3-4-10-6-8(7)5-9/h1-2,5,10-11H,3-4,6H2
• InChI Key: RADQTHXRZJGDQI-UHFFFAOYSA-N
• Exact Mass: 149.084063974
• Molecular Formula: C9H11NO
• Molecular Weight: 149.19
• SMILES: C1CNCC2=C1C=CC(=C2)O
• Topological: 32.3
• Monoisotopic Mass: 149.084063974
• Synonyms: 1,2,3,4-tetrahydroisoquinolin-7-ol, 30798-64-2, DTXSID40329303, DTXCID80280404, 813-057-9, 7-Hydroxy-1,2,3,4-tetrahydroisoquinoline, 1,2,3,4-Tetrahydro-isoquinolin-7-ol, 7-Isoquinolinol, 1,2,3,4-tetrahydro-, CHEMBL27730, 1,2,3,4-Tetrahydro-7-isoquinolinol, MFCD08234812, 7-Hydroxytetrahydroisochinolin, SCHEMBL354222, SCHEMBL354223, SCHEMBL470826, SCHEMBL9756716, SCHEMBL9756717, FBA79864, BDBM50024826, AKOS006222928, AC-9597, MB05747, BS-13490, PD179125, DB-029368, 7-Hydroxy-1,2,3,4-tetrahydro-isoquinoline, CS-0096274, EN300-39187, G28592, AB01007426-01, Z382690838

Application

1,2,3,4-Tetrahydroisoquinolin-7-ol serves as a key intermediate in the synthesis of bioactive compounds, particularly in the development of central nervous system (CNS) targeting drugs. Researchers utilize this compound in the study of neurotransmitter analogs and potential therapeutic agents for neurological disorders. Its structural framework makes it valuable for exploring dopaminergic and adrenergic receptor interactions in medicinal chemistry programs.

Safety and Hazards

GHS Hazard Statements

• H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
• H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
• H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
• H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
• H412 (100%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]

Precautionary Statements

• P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Hazard Classes and Categories

• Acute Tox. 4 (100%)
• Skin Irrit. 2 (100%)
• Eye Irrit. 2A (100%)
• STOT SE 3 (100%)
• Aquatic Chronic 3 (100%)

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.